Product Paramenters Dimensions: 170mm x 180mm x 118mm 290mm x 180mm x 134mm Weight : 1.5kg 2.5kg (with the humidifier) Water Capacity: 350ml at recommendadwater level Ramp the ramp time ranges from 0 to 60 mintes Humidifier Setting off, 1 to 5 (90 �°F to 167 �°F/35 �°C to 75 �°C ï¼? Output No less than 10 mg H20/L Sp02 Range: 0 to 100% Pulse Rate 40 to 240 BPM AC power Consumption 100 -240 VAC, 50/60 Hz Max 2 A
Rapid SAR-CoV-2 (Covid-19) Test Kits: FDA & CE Approved (Results in 15 min). SAR-CoV-2 IgG/IgM Rapid Test Cassette is a qualitative membrane based immunoassay for the detection of IgG and IgM antibodies to SAR-CoV-2 in human whole blood, serum or plasma specimen. Made in China: FDA and CE Approved, China NMPA approval (export allowed) One of the earliest CE (Feb 2020) and FDA (Mar 2020) approved kit. Clinically studied and reliable. Packaging: 20 sets/box or 40 sets/box. Payment term: MOQ 2000 sets, FOB China $ 9.5/set. < 10000 sets 100% advance payment > 10000 sets L/C ex-work on site
Our COVID-19 rapid test kit can be used effectively on many levels for proper screening and strategic preparedness toward the pandemic. The test kit requires no sophisticated equipment nor laboratory settings. Our SARS-COV-2 Antibody Rapid Test Kit can be applied for screening of COVID-19 disease on the following: General practitioners and external clinics level to detect previous SARS-COV-2 viral infections on both symptomatic and asymptomatic patients. Determination of the immunity level of front-line healthcare workers, which can help in the development of pandemic preparedness strategies at national levels. Epidemiological COVID-19 surveys at national and district levels for research purposes. Airport screening for arriving /departing passengers to control the pandemic in the aviation industry. Suspected cases exclusion to minimize cost and time spent in the RT-PCR testing procedures. Screening on the national level to facilitate decision making regarding lockdown and curfew easing strategies. Phoenix Bioscience is offering a competitive price for a high-quality kit that is made in Canada and used currently to combat the pandemic in most American cities.
We at Phoenix Bioscience would like to offer you our COVID-19 rapid detection kit based on detecting SARS-COV-2 IgG and IgM and delivers results within 15 minutes. Made in Canada, CE certified. Packaging Details: Each package contains 25 individually packed tests, the buffer used in the detection procedure, and disposable pipettes for blood samples collection Phoenix Bioscience is offering a competitive price for a high-quality kit
Designed for qualitative detection of SARS-CoV-2 antibodies in human serum, plasma, and whole blood samples, novel coronavirus antibody detection reagent (Colloidal Gold Method) is regarded as auxiliary detection metrics towards on-site screening for suspected cases that have the negative results after nucleic acid testing. This rapid test can aid in the diagnosis of coronavirus infection and significantly shorten the detection time, yielding the results in 15 minutes.
Rapid SAR-CoV-2 (Covid-19) Test Kits: FDA & CE Approved (Results in 15 min). SAR-CoV-2 IgG/IgM Rapid Test Cassette is a qualitative membrane based immunoassay for the detection of IgG and IgM antibodies to SAR-CoV-2 in human whole blood, serum or plasma specimen. Made in China: FDA and CE Approved, China NMPA approval (export allowed) One of the earliest CE (Feb 2020) and FDA (Mar 2020) approved kit. Clinically studied and reliable. Packaging: 20 sets/box or 40 sets/box. Payment term: MOQ 2000 sets, FOB China $ 9.5/set. < 10000 sets 100% advance payment > 10000 sets L/C ex-work on site
1. Principle This kit is based on the specific reaction of antibody-antigen and immunochromatography. β-lactam and tetracyclines antibiotics in the sample compete for the antibody with the antigen coated on the membrane of the test strip. Then after a color reaction, the result can be observed. 2. Applications This kit is used for rapid qualitative analysis of β-lactam and tetracyclines in milk sample.
COVID-19 Rapid 99% Accuracy Mouth Testing Kits: Serology Antibody Testing $49.97 (FDA APPROVED) It is a 10-minute test that does not require a machine. â?¢ Antigen Rapid Testing $59.97 (FDA Emergency Use Authorization - EUA) It is a 20-minute test that does not require a machine or cold chain logistics� (as compared to PCR swab tests). Volume Discounts 10,000 plus units $5 per kit discount 20,000 plus units $7 per kit discount 50,000 plus units $10 per kit discount *Special Discount Structure for (immediate) higher volume orders* Please email for more information.
2.8million Covid-19 Rapid Test Kits In Stock
D2 Diesel Gas Oil L-0.2-62 DOST305-82 D6 Diesel Bunker Fuel
We have en590 a1 and d6 that we are trying to distribute before our refinery close for the year , so only real buyers thats rwa and no time waister we have about 20 days left untill next year
Disposable Plastic Tubes with Cap
Min 25,000 Max 200,000 tons in stock this month
Injection molded from medical grade FHR polypropylene our swab is based on the Harvard Wyss Institute Design and meets the specifications of Health Canada. The swab is also registered with the FDA. Our process allows us to produce approximately 60,000 swabs daily and are ideal for testing or to be included in test kits. The price includes gamma sterilization and individually packaged. Website is www.covidtestswab.com Specifications are as follows: Overall swab length 149.80 mm Breakpoint distance from tip 75.75 mm Swab tip length 20 mm
CLIA Waived Use of this test with all authorized specimen types is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests. This test is also authorized for use with fingerstick whole blood specimens only at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. The CLIA Waived COVID-19 IgG/IgM Rapid Test Device is an in vitro immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Emergency use of this test is limited to authorized laboratories. About Test Device EUA Authorized CE Mark Test does NOT give positive or negative result for COVID-19 virus. This is an antibody test, it only indicates past or recent infection. Read Results in 15 Minutes 9 Month Expiration from Date of Manufacture Contents 20 Test Devices 20 Disposable Pipettes 20 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert
The CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within the first five days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet the requirements to perform moderate, high, or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., inpatient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. Lateral flow assay Detect SARS-CoV-2 nucleocapsid protein antigen Rapid results within 10-15 minutes Intended at POC setting (i.e., in patient care settings) by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation For use under the Emergency Use Authorization (EUA) only For in vitro diagnostic use only For prescription use only For use with direct anterior nasal and nasopharyngeal swab specimens Clinical Performance 93.75% PPAa and 99.32% NPAb when used with nasopharyngeal swab 87.18% PPAa and 100% NPAb when used with anterior nasal swab
Master Carton - Contains 625 Tests For International Sale Only - Call for Pricing The COVID-19 IgG/IgM Rapid Test Device is an in vitro Immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. About Test Device Gives Positive or Negative Result for COVID-19 IgM/IgG antibodies Read Results in 15 Minutes Contents of each box 25 Test Devices 25 Disposable Pipettes 25 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert
7 packs retail for $0.99 Container information 1 Carton 2450 pcs 7 pcs x (350 pk) 1 container 760 Cartons (760 x 2450) = 1,862,000 pcs
Certification - Test report-Certified Daily manufacturer output - 200,000 Price - $15.00 per test
Specification Product Name VivaDiag SARS-CoV-2 IgM/IgG Rapid Test (COVID-19 IgM/IgG Rapid Test) Test Principle Colloidal gold Sample Type Whole blood (fingertip/venous ), serum or plasma Sample Volume 10 �¼L Test Time 15 min Operation Temperature 15-30 Storage Temperature 2-30 Shelf Life (Unopened) 24 months
